Fortress Biotech (FBIO) announced that Lucy Lu, M.D., has been appointed to its Board of Directors. Dr. Lu is an accomplished executive with over 20 years of experience in a wide range of financial and drug development matters in the biotech and healthcare sectors as an investment banker, equity research analyst and executive at several biotech companies. Since April of 2022, Dr. Lu has served as Chief Operating Officer of Innovative Cellular Therapeutics. Additionally, she is currently a member of the Board of Directors of Inventiva (IVA).
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on FBIO:
- Journey Medical Corporation Announces Positive Comparative Pharmacokinetic (PK) Data for DFD-29
- Fortress Biotech Appoints Lucy Lu, M.D., to its Board of Directors
- Urica Therapeutics Expands Exclusive License Agreement with Fuji Yakuhin Co. Ltd. to Develop Dotinurad in Additional Territories Including Turkey and the Middle East and North Africa
- Fortress Biotech’s Urica expands exclusive license agreement with Fuji Yakuhin
- Fortress Biotech to Participate in Cantor Medical & Aesthetic Dermatology, Ophthalmology & MedTech/Diagnostic Conference